Bangkok, 19 November 2013 – Mega Lifesciences Public Company Limited, a leading consumer healthcare and pharmaceutical company since 1985, has marked its first trading day on the Stock Exchange of Thailand (SET). The company started trading today on the SET main board under the ticker symbol ‘MEGA’.

At the listing ceremony, Mr. Vivek Dhawan, CEO & Chief Coach, Mega Lifesciences Public Company Limited said “I would like to welcome our new shareholders on this Mega growth journey. I look forward to joining with them as we grow our mission to help people stay healthy as long as they live, while building a great company, from Thailand to the world.”

With market leading brands of nutraceuticals, pharmaceuticals and over-the-counter products in 29 developing countries, and as a leading distributor of pharmaceuticals and consumer goods in Myanmar, Vietnam and Cambodia, Mega Lifesciences has demonstrated consistent growth, including a 19.8% compound annual growth rate from 2010 to 2012, and 21% revenue growth in 1H 2013 vs 1H 2012.

Seen in the photo are: Vivek Dhawan (4th from left), CEO & Chief Coach, Mega Lifesciences Public Company Limited, Mr. Thomas Abraham (6th from left), CFO & Coach, Duangnapa Tongsiri (2nd from left), Managing Director – Thailand Division & Coach, Dr. Sathit Limpongpan (3rd from left), Chairman, The Stock Exchange of Thailand, Charamporn Jotikasthira (5th from left), President, The Stock Exchange of Thailand, Thiti Tantikulanan (7th from left), Executive Chairman, Kasikorn Securities Public Company Limited, and Suchai Sutasthumkul (left), Chief Executive Officer, CIMB Securities (Thailand).